Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2304 (LINC02304)
- Target
- LINC02304
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
LINC02304 (Long intergenic non-protein coding RNA 2304) is a human gene that produces a long non-coding RNA transcript, classified as a long intergenic non-coding RNA (lincRNA)[1][5]. These RNAs are typically over 200 nucleotides long, do not overlap with protein-coding genes, and are transcribed independently[5]. While lincRNAs have diverse biological roles—including regulation of gene expression and genome architecture—there are no established biological functions or disease associations for LINC02304 specifically[1]. LINC02304 is not considered a therapeutic target and is not currently associated with any biomarkers, safety concerns, or drug interactions[1]. The canonical name and abbreviation are accurate, with no evidence of misclassification or common alternative aliases.
- Other names
- LINC02304
02
Mechanism of action
null
03
Biological functions
Currently undefined for LINC02304 specifically.The general class of lincRNAs is involved in chromatin remodeling, genome architecture, transcription regulation, enhancer-associated activity, and stabilization/modulation of RNA expression.No unique biological function for LINC02304 has been described in current literature.
04
Disease associations
No specific disease associations or roles have been reported for LINC02304.Other lincRNAs are involved in cancer and other regulatory processes, but LINC02304 has not been explicitly linked to any disease.
05
Safety considerations
None known.There are no therapeutic applications or challenges reported for LINC02304.
06
Biomarkers
None known for patient selection or efficacy monitoring.Other lincRNAs are occasionally used as biomarkers, but not LINC02304.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2304 (LINC02304).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2304 (LINC02304).